Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Urologia|November 19, 2010
[State of the art and controversies in the treatment of testis germ-cell tumors (TGT)]R Salvioni, N Nicolai, A Necchi, et al.
Leukemia & Lymphoma|January 1, 1992
An Italian experience of high-dose chemotherapy and autologous bone marrow transplantation (ABMT) in germ cell tumours. Suggestions for future directionG Rosti, L Albertazzi, A Tienghi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 1, 1996
[Therapeutic alternatives in the treatment of class T1N0 squamous cell carcinoma of the penis: indications and limitations]L Piva, N Nicolai, A Di Palo, et al.
La Radiologia Medica|October 25, 2011
CT-guided percutaneous cryoablation of renal masses in selected patientsC Spreafico, N Nicolai, R Lanocita, et al.
Tumori|June 30, 1983
Hormone treatment and sex steroid receptors in metastatic renal cell carcinoma: report of a multicentric prospective studyG Pizzocaro, G Di Fronzo, V Cappelletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trialA Necchi, S Lo Vullo, P Giannatempo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2013
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomesA Necchi, N Nicolai, L Mariani, et al.
European Urology|January 1, 1983
Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trialG Pizzocaro, G Di Fronzo, L Piva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2007
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international studyK Fizazi, J Oldenburg, A Dunant, et al.
Investigational New Drugs|February 26, 2014
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trialA Necchi, P Giannatempo, L Mariani, et al.
Pageof 5